Investors Become Goldilocks in a Bear Market

I AM BIO

English - May 31, 2022 09:00 - 25 minutes - 23.7 MB - ★★★★★ - 67 ratings
Life Sciences Science Health & Fitness Medicine coronavirus covid virus biopharmaceuticals biotech patients biotechnology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Drug Prices: A Dysfunctional Market Limits Patient Access

Next Episode: Data Storage Crisis: DNA to the Rescue

Current market trends have put investors in a “flight-to-safety” mentality, especially when it comes to biotech companies. What does this mean for getting biotech innovations to the marketplace? This episode explores the daunting challenge of raising capital in a bear market.

Speakers:

Bill Newell, Sutro BiopharmaDr. Lisa Drakeman, Biotech EntrepreneurSougato Das, PRISM.science